Jesse Lebaron, PA
Medical · Sarasota, FLNPI 1851879217
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 597 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 597 payments — averaging $26.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sun Pharmaceutical Industries Inc.$2K
- Johnson & Johnson$2K
- Arcutis Biotherapeutics, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$932
- Galderma Laboratories, L.p.$838
- plus $7K from 31 others
What the payments were for
- Speaking & faculty fees$851%
- Food & beverage$15,32797%
- Education$4563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 99 | $2,590 |
| Sun Pharmaceutical Industries Inc. | 69 | $1,646 |
| Johnson & Johnson | 65 | $1,537 |
| Arcutis Biotherapeutics, Inc. | 37 | $1,070 |
| E.r. Squibb & Sons, L.L.C. | 42 | $932 |
| Galderma Laboratories, L.p. | 26 | $838 |
| Lilly USA, LLC | 22 | $681 |
| Regeneron Healthcare Solutions, Inc. | 30 | $671 |
| Novartis | 35 | $599 |
| UCB, Inc. | 11 | $586 |
| Sanofi | 21 | $563 |
| Amgen | 16 | $390 |
| Incyte Corporation | 12 | $368 |
| Verrica Pharmaceuticals Inc. | 8 | $345 |
| Pfizer | 13 | $298 |
| Revance Therapeutics, Inc. | 5 | $288 |
| Mayne Pharma Commercial LLC | 15 | $272 |
| Janssen Scientific Affairs, LLC | 3 | $237 |
| LEO Pharma Inc. | 6 | $234 |
| Dermavant Sciences, Inc. | 7 | $207 |
| Boehringer Ingelheim | 8 | $202 |
| Journey Medical Corporation | 4 | $170 |
| Botanix SB Inc | 4 | $155 |
| Organon | 4 | $147 |
| Merz North America, Inc. | 2 | $142 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $128 |
| EPI Health, LLC | 3 | $119 |
| Kerecis Limited | 2 | $91 |
| Convatec Inc. | 3 | $75 |
| Genentech USA, Inc. | 4 | $59 |
| Biofrontera Inc. | 3 | $54 |
| Strata Skin Sciences, Inc. | 5 | $41 |
| Smith+Nephew | 2 | $39 |
| Organogenesis Inc. | 1 | $29 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $24 |
| Almirall LLC | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,867 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $127,507 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $108,507 |
| Clobetasol Propionate | 63 | $2,550 |
| Fluorouracil | 36 | $2,496 |
| Ketoconazole | 130 | $1,574 |
| Triamcinolone Acetonide | 89 | $927 |
| Doxycycline Hyclate | 34 | $859 |
| Betamethasone Dipropionate | 20 | $645 |
| Clindamycin Phosphate | 49 | $615 |
| Fluocinonide | 14 | $476 |
| Hydroxyzine Hcl | 32 | $383 |
| Mupirocin | 51 | $339 |
| Ciclopirox | 13 | $326 |
| Nystatin | 39 | $288 |
| ValacyclovirValacyclovir Hcl | 19 | $200 |
Paid to pharmacies, not to this prescriber.
Other medical in Sarasota
- Matthew JohnsonSarasota$16K
- Amy TraSarasota$16K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.